TGFP-CAP peptide and its uses
The present invention relates to a GFP-CAP peptide having an amino acid sequence derived from TGF- 1 (transforming growth factor- 1) and a cell adhesion sequence, wherein the amino acid sequence derived from TGF- 1 consists of the amino acid sequence of SEQ ID NO:1 and the TGFP-CAP peptide is repres...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a GFP-CAP peptide having an amino acid sequence derived from TGF- 1 (transforming growth factor- 1) and a cell adhesion sequence, wherein the amino acid sequence derived from TGF- 1 consists of the amino acid sequence of SEQ ID NO:1 and the TGFP-CAP peptide is represented by the following formula I: Ile-Trp-Ser-Leu-Asp-Thr-Gln-Tyr-Cell adhesion sequence (I). The TGFP-CAP peptide of the present invention exhibits excellent anti-angiogenic activity. In addition, the TGFP-CAP peptide of the present invention prevents effectively melanin generation in skin to have skin whitening effects. The present peptide shows much higher stability and permeability to skin than natural-occurring TGF- 1. Such plausible activities and safety of the present peptide enable advantageously to application to drugs, quasi-drugs and cosmetics. |
---|